Latest period
$63M
YoY change
0.0%
5Y CAGR
-1.9%
Peak year (FY2020)
$97M
Latest annual
$88M
Stock-Based Compensation history chart for Quest Diagnostics (DGX) from 2016 to 2025
Latest: $88M
Stock-Based Compensation growth chart for Quest Diagnostics (DGX) from 2016 to 2025
Latest: 0.0%
Stock-Based Compensation history table for Quest Diagnostics (DGX) from 1996 to 2025
| FY2025 | $88M | 0.0% | $0.00 | ||
| FY2024 | $88M | +14.3% | +$11M | ||
| FY2023 | $77M | 0.0% | $0.00 | ||
| FY2022 | $77M | -2.5% | -$2M | ||
| FY2021 | $79M | -18.6% | -$18M | ||
| FY2020 | $97M | +73.2% | +$41M | ||
| FY2019 | $56M | -8.2% | -$5M | ||
| FY2018 | $61M | -22.8% | -$18M | ||
| FY2017 | $79M | +14.5% | +$10M | ||
| FY2016 | $69M | +32.7% | +$17M | ||
| FY2015 | $52M | +2.0% | +$1M | ||
| FY2014 | $51M | +82.1% | +$23M | ||
| FY2013 | $28M | -44.3% | -$22.3M | ||
| FY2012 | $50.3M | -30.0% | -$21.6M | ||
| FY2011 | $71.9M | +33.4% | +$18M | ||
| FY2010 | $53.9M | -28.2% | -$21.2M | ||
| FY2009 | $75.1M | +6.4% | +$4.5M | ||
| FY2008 | $70.6M | — | +$70.6M | ||
| FY2007 | $0.00 | — | $0.00 | ||
| FY2006 | $0.00 | — | $0.00 | ||
| FY2005 | $0.00 | — | $0.00 | ||
| FY2004 | $0.00 | — | $0.00 | ||
| FY2003 | $0.00 | — | $0.00 | ||
| FY2002 | $0.00 | — | $0.00 | ||
| FY2001 | $0.00 | — | $0.00 | ||
| FY2000 | $0.00 | — | $0.00 | ||
| FY1999 | $0.00 | — | $0.00 | ||
| FY1998 | $0.00 | — | $0.00 | ||
| FY1997 | $0.00 | — | $0.00 | ||
| FY1996 | $0.00 | — | — |
- FY2025$88M0.0%
- FY2024$88M+14.3%
- FY2023$77M0.0%
- FY2022$77M-2.5%
- FY2021$79M-18.6%
- FY2020$97M+73.2%
- FY2019$56M-8.2%
- FY2018$61M-22.8%
- FY2017$79M+14.5%
- FY2016$69M+32.7%
- FY2015$52M+2.0%
- FY2014$51M+82.1%
- FY2013$28M-44.3%
- FY2012$50.3M-30.0%
- FY2011$71.9M+33.4%
- FY2010$53.9M-28.2%
- FY2009$75.1M+6.4%
- FY2008$70.6M—
- FY2007$0.00—
- FY2006$0.00—
- FY2005$0.00—
- FY2004$0.00—
- FY2003$0.00—
- FY2002$0.00—
- FY2001$0.00—
- FY2000$0.00—
- FY1999$0.00—
- FY1998$0.00—
- FY1997$0.00—
- FY1996$0.00—
Stock-Based Compensation values are taken from Quest Diagnostics's reported cash flow statements (quarterly 10-Q and annual 10-K filings with the U.S. Securities and Exchange Commission). Each row shows the period end date and the filing date. YoY compares each figure to the same period one year earlier. Amounts are in USD as filed.
About Stock-Based Compensation at Quest Diagnostics (DGX)
Stock-Based Compensation for Quest Diagnostics (DGX): headline value $63M · YoY 0.0%. Annual and quarterly series, chart, and tables are below.
Headline figure above is from the reporting period ending (reported ). Chart and table below cover the full reported history back to .
Quest Diagnostics (DGX) most recent annual stock-based compensation stands at $88M (2025) – edged up 0.0% year-over-year.
Looking at the 2020–2025 (5 years) stretch, Quest Diagnostics stock-based compensation compounded at -1.9% per year, with a net decline across the window.
The record annual stock-based compensation stands at $97M, reached in 2020; the historical low of $0.00 was recorded in 1996.
Quest Diagnostics Stock-Based Compensation by Year
Quest Diagnostics Stock-Based Compensation 2025: $88M
Quest Diagnostics posted stock-based compensation of $88M in 2025, edged up 0.0% from 2024.
Quest Diagnostics Stock-Based Compensation 2024: $88M
In 2024, Quest Diagnostics reported stock-based compensation of $88M, grew 14.3% from 2023.
Quest Diagnostics Stock-Based Compensation 2023: $77M
Quest Diagnostics stock-based compensation in 2023 was $77M, edged up 0.0% from 2022.
Quest Diagnostics Stock-Based Compensation 2022: $77M
2022's stock-based compensation for Quest Diagnostics came in at $77M, edged down 2.5% below 2021.
Quest Diagnostics Stock-Based Compensation 2021: $79M
Quest Diagnostics stock-based compensation in 2021 was $79M.
See more financial history for Quest Diagnostics (DGX).
Sector peers by Stock-Based Compensation
Healthcare peers of Quest Diagnostics (DGX), ranked by their latest stock-based compensation
| $1.35B | |
| $971M | |
| $955M | |
| $626M | |
| $494M | |
| $310M | |
| $0.00 | |
| $0.00 |
- $1.35B
- $955M
- $626M
- $494M
- $0.00
- $0.00
Frequently asked questions
Quest Diagnostics (DGX) Key Financials
Charts, filings, and peer comparison for every metric
Explore more
Deep-dives across the income statement, cash flow, capital return, and valuation
- Buybacks2.37% TTM
- Dividend Profile1.41% yield
- Dividend Calculator
- Dividend Forecast
- Dividend Capture
- Stock Split History2 splits
How this company returns cash to shareholders — buybacks, dividends, and stock splits.